BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 25078536)

  • 21. The Association of HIV Control and Immunosuppression With Risk of Non-AIDS-Defining Cancer Risk Among Patients on Antiretroviral Therapy.
    Dickey BL; Yanik EL; Thompson Z; Burkholder G; Kitahata MM; Moore RD; Jacobson J; Mathews WC; Christopoulos KA; Fleming J; Napravnik S; Achenbach C; Coghill AE
    J Acquir Immune Defic Syndr; 2024 Mar; 95(3):275-282. PubMed ID: 37977197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systematic review on cumulative HIV viraemia among people living with HIV receiving antiretroviral treatment and its association with mortality and morbidity.
    Mesic A; Decroo T; Florence E; Ritmeijer K; van Olmen J; Lynen L
    Int Health; 2024 May; 16(3):261-278. PubMed ID: 37823452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of CD4 + cell count and HIV viral load with risk of non-AIDS-defining cancers.
    Ma Y; Zhang J; Yang X; Chen S; Weissman S; Olatosi B; Alberg A; Li X
    AIDS; 2023 Nov; 37(13):1949-1957. PubMed ID: 37382882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cumulative Human Immunodeficiency Virus (HIV)-1 Viremia Is Associated With Increased Risk of Multimorbidity Among US Women With HIV, 1997-2019.
    Morton ZP; Christina Mehta C; Wang T; Palella FJ; Naggie S; Golub ET; Anastos K; French AL; Kassaye S; Taylor TN; Fischl MA; Adimora AA; Kempf MC; Tien PC; Ofotokun I; Sheth AN; Collins LF
    Open Forum Infect Dis; 2023 Feb; 10(2):ofac702. PubMed ID: 36751648
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A simple CD4+ T cells to FIB-4 ratio for evaluating prognosis of BCLC-B hepatocellular carcinoma: a retrospective cohort study.
    Zhao Y; Kong LX; Feng FS; Yang J; Wei G
    BMC Cancer; 2022 Mar; 22(1):311. PubMed ID: 35321670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Associations Between Plasma Human Immunodeficiency Virus (HIV) Ribonucleic Acid Levels and Incidence of Invasive Cancer in People With HIV After Initiation of Combination Antiretroviral Therapy.
    Elvstam O; Marrone G; Medstrand P; Treutiger CJ; Svedhem V; Gisslén M; Björkman P
    Open Forum Infect Dis; 2021 Jun; 8(6):ofab131. PubMed ID: 34189159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. All-Cause Mortality and Serious Non-AIDS Events in Adults With Low-level Human Immunodeficiency Virus Viremia During Combination Antiretroviral Therapy: Results From a Swedish Nationwide Observational Study.
    Elvstam O; Marrone G; Medstrand P; Treutiger CJ; Sönnerborg A; Gisslén M; Björkman P
    Clin Infect Dis; 2021 Jun; 72(12):2079-2086. PubMed ID: 32271361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cumulative HIV Viremia Copy-Years and Hypertension in People Living with HIV.
    Xu Y; Chen X; Wijayabahu A; Zhou Z; Yu B; Spencer EC; Cook RL
    Curr HIV Res; 2020; 18(3):143-153. PubMed ID: 32003696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIV and cancer in the Veterans Health Administration System.
    Sigel K; Park L; Justice A
    Semin Oncol; 2019; 46(4-5):334-340. PubMed ID: 31703932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV RNA, CD4+ Percentage, and Risk of Hepatocellular Carcinoma by Cirrhosis Status.
    Torgersen J; Kallan MJ; Carbonari DM; Park LS; Mehta RL; D'Addeo K; Tate JP; Lim JK; Goetz MB; Rodriguez-Barradas MC; Gibert CL; Bräu N; Brown ST; Roy JA; Taddei TH; Justice AC; Lo Re V
    J Natl Cancer Inst; 2020 Jul; 112(7):747-755. PubMed ID: 31687755
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bias in the estimation of cumulative viremia in cohort studies of HIV-infected individuals.
    Lesosky M; Glass T; Rambau B; Hsiao NY; Abrams EJ; Myer L
    Ann Epidemiol; 2019 Oct; 38():22-27. PubMed ID: 31537405
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of Immunosuppression and Human Immunodeficiency Virus (HIV) Viremia With Anal Cancer Risk in Persons Living With HIV in the United States and Canada.
    Hernández-Ramírez RU; Qin L; Lin H; Leyden W; Neugebauer RS; Althoff KN; Hessol NA; Achenbach CJ; Brooks JT; Gill MJ; Grover S; Horberg MA; Li J; Mathews WC; Mayor AM; Patel P; Rabkin CS; Rachlis A; Justice AC; Moore RD; Engels EA; Silverberg MJ; Dubrow R;
    Clin Infect Dis; 2020 Mar; 70(6):1176-1185. PubMed ID: 31044245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk and Predictors of Esophageal and Stomach Cancers in HIV-Infected Veterans: A Matched Cohort Study.
    Thrift AP; Kramer JR; Hartman CM; Royse K; Richardson P; Dong Y; Raychaudhury S; Desiderio R; Sanchez D; Anandasabapathy S; White DL; Chiao EY
    J Acquir Immune Defic Syndr; 2019 Jul; 81(3):e65-e72. PubMed ID: 30939533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Viremia copy-years and mortality among combination antiretroviral therapy-initiating HIV-positive individuals: how much viral load history is enough?
    Wang R; Haberlen SA; Palella FJ; Mugavero MJ; Margolick JB; Macatangay BJC; Martínez-Maza O; Jacobson LP; Abraham AG
    AIDS; 2018 Nov; 32(17):2547-2556. PubMed ID: 30379686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of Viral Suppression With Lower AIDS-Defining and Non-AIDS-Defining Cancer Incidence in HIV-Infected Veterans: A Prospective Cohort Study.
    Park LS; Tate JP; Sigel K; Brown ST; Crothers K; Gibert C; Goetz MB; Rimland D; Rodriguez-Barradas MC; Bedimo RJ; Justice AC; Dubrow R
    Ann Intern Med; 2018 Jul; 169(2):87-96. PubMed ID: 29893768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Are Non-HIV Malignancies Increased in the HIV-Infected Population?
    Thrift AP; Chiao EY
    Curr Infect Dis Rep; 2018 May; 20(8):22. PubMed ID: 29804238
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overview of cancer incidence and mortality among people living with HIV/AIDS in British Columbia, Canada: Implications for HAART use and NADM development.
    Chiu CG; Smith D; Salters KA; Zhang W; Kanters S; Milan D; Montaner JSG; Coldman A; Hogg RS; Wiseman SM
    BMC Cancer; 2017 Apr; 17(1):270. PubMed ID: 28410587
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immediate Antiretroviral Therapy Reduces Risk of Infection-Related Cancer During Early HIV Infection.
    Borges ÁH; Neuhaus J; Babiker AG; Henry K; Jain MK; Palfreeman A; Mugyenyi P; Domingo P; Hoffmann C; Read TR; Pujari S; Meulbroek M; Johnson M; Wilkin T; Mitsuyasu R;
    Clin Infect Dis; 2016 Dec; 63(12):1668-1676. PubMed ID: 27609756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reevaluating Cumulative HIV-1 Viral Load as a Prognostic Predictor: Predicting Opportunistic Infection Incidence and Mortality in a Ugandan Cohort.
    Sempa JB; Dushoff J; Daniels MJ; Castelnuovo B; Kiragga AN; Nieuwoudt M; Bellan SE
    Am J Epidemiol; 2016 Jul; 184(1):67-77. PubMed ID: 27188943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer prevention in HIV-infected populations.
    Goncalves PH; Montezuma-Rusca JM; Yarchoan R; Uldrick TS
    Semin Oncol; 2016 Feb; 43(1):173-188. PubMed ID: 26970136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.